<?xml version="1.0" encoding="UTF-8"?>
<p id="p0725">Treatment of short-lived, mild to moderate histoplasmosis is not usually required in immunocompetent patients. Treatment of chronic histoplasmosis is with systemic antifungals, e.g., itraconazole. Severe or disseminated disease is managed with intravenous antifungals, e.g., amphotericin [
 <xref rid="bib88" ref-type="bibr">88</xref>]. Histoplasmosis is one of the commonest opportunistic infections in patients receiving TNF alpha-blockers and often presents with pneumonitis and/or disseminated infection [
 <xref rid="bib89" ref-type="bibr">89</xref>].
</p>
